Skip to main content

BioNTech to produce vaccines in Singapore, its new regional headquarters

The new manufacturing site would be able to produce several hundred of million doses of mRNA-based vaccines per year, depending on the type, BioNTech said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.